- Home
- AAT vs SLNO Comparison
AAT vs SLNO Comparison
Compare AAT & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AAT | SLNO |
|---|---|---|
| Founded | 1967 | 1999 |
| Country | United States | United States |
| Employees | 208 | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 2.3B |
| IPO Year | 2010 | 2014 |
Fundamental Metrics
Financial Performance| Metric | AAT | SLNO |
|---|---|---|
| Price | $18.16 | $30.02 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 2 | 11 |
| Target Price | $19.50 | ★ $105.27 |
| AVG Volume (30 Days) | 329.5K | ★ 1.5M |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | ★ 7.33% | N/A |
| EPS Growth | N/A | ★ 108.90 |
| EPS | ★ 0.92 | 0.39 |
| Revenue | ★ $436,204,000.00 | $1,450,788.00 |
| Revenue This Year | $4.38 | $150.65 |
| Revenue Next Year | $0.20 | $56.10 |
| P/E Ratio | ★ $20.15 | $81.72 |
| Revenue Growth | N/A | ★ 138.82 |
| 52 Week Low | $16.69 | $30.11 |
| 52 Week High | $21.40 | $89.12 |
Technical Indicators
Market Signals| Indicator | AAT | SLNO |
|---|---|---|
| Relative Strength Index (RSI) | 39.51 | 27.96 |
| Support Level | $17.75 | N/A |
| Resistance Level | $19.41 | $41.48 |
| Average True Range (ATR) | 0.40 | 1.85 |
| MACD | -0.10 | -0.35 |
| Stochastic Oscillator | 1.61 | 5.83 |
Price Performance
Historical ComparisonAbout AAT American Assets Trust Inc.
American Assets Trust Inc is a self-administered real estate investment trust based in the United States. The company invests in, operates, and develops retail, office, residential, and mixed-use properties. Properties are predominantly located in South California, Northern California, Oregon, Washington, and Hawaii. American Assets operates through four segments based on property type: retail; office; mixed-use, which consists of retail and hotel components; and multifamily, which includes the company's apartment properties. The retail and office segments collectively contribute the majority of the total revenue.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.